1 articles published in Selcuk Medical Journal with the keyword "biyolojikler": Safety of Biologic Agents in the Treatment of Psoriasis Vulgaris: An Integrated Review of Clinical Trials and Real-World Evidence
BURHAN ENGIN, EMRE BAYINDIR
2026, Vol 42, Issue 1, Page 80-89
Psoriasis vulgaris is a chronic, immune-mediated inflammatory disease in which dysregulation of the TNF-α and IL-23/Th17 axes drives keratinocyte hyperproliferation and systemic comorbidities. Targeted biologic drugs-TNF-α inhibitors, the IL-12/23 p40 inhibitor ustekinumab, IL-23 p19 inhibitors,...
